Page last updated: 2024-08-18

pyrroles and Alopecia Cicatrisata

pyrroles has been researched along with Alopecia Cicatrisata in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (4.76)29.6817
2010's25 (59.52)24.3611
2020's15 (35.71)2.80

Authors

AuthorsStudies
AlAnazi, R; AlHarithy, R; AlHayaza, G; AlIssa, A; AlKhalifah, A; AlMarzoug, A; AlOrainy, M; AlSheikh, A; AlTawil, L1
Dunnick, CA; Kibbie, J; Kines, K; Norris, D1
Benton, S; Farah, R; Freese, R; Hordinsky, M1
Albayda, J; Castillo, R1
Bordone, LA; Fan, W; Lavian, J; Lee, EY; Youssef, S1
Arias-Santiago, S; Cantudo-Cuenca, MR; Diaz-Calvillo, P; Molina-Leyva, A; Rodriguez-Pozo, JA; Sanchez-Diaz, M; Tercedor-Sánchez, J1
Geng, SL; Gong, T; Ji, C; Su, HH1
Abdulla, N; Al-Obaidli, A; Ali-Alam, M; Husein-ElAhmed, H; Steinhoff, M1
Akdogan, N; Atakan, N; Doğan, S; Ersoy-Evans, S1
Jerjen, R; Meah, N; Sinclair, R; Trindade de Carvalho, L; Wall, D1
Lomborg, N; Lottenburger, T1
Maksimow, A; Stintzing, D; Wohlrab, J1
Dincer, D; Kose Ozkan, C; Tanacan, E1
Kamath, S1
Castelo-Soccio, L; McKenzie, PL1
Bhoyrul, B; Kerkemeyer, KLS; Sinclair, RD1
Castelo-Soccio, L1
Kim, BY; Kim, HS1
Avila, L; Lo Sicco, K; Shapiro, J; Strazzulla, LC1
Adışen, E; Aksakal, AB; Erduran, F1
Deenonpoe, R; Meephansan, J; Ponnikorn, S; Suchonwanit, P; Thummakriengkrai, J; Yingmema, W1
Pandey, M; Ramasamy, M; Shukla, M1
Castelo-Soccio, L; Putterman, E1
Bokhari, L; Sinclair, R1
Bordone, LA; Christiano, AM; Khanna, T; Sallee, B; Yang, CC1
Cho, S; Huh, CH; Kim, MW; Kwon, O; Lee, JS; Park, HS; Shin, JW1
Almutairi, N; Hussain, NH; Nour, TM1
Chen, CC; Dai, YX1
Cuenca-Barrales, C; Linares-Gonzalez, L; Ródenas-Herranz, T; Ruiz-Villaverde, R1
Santos, LDN; Shapiro, J1
Cranwell, WC; De Cruz, R; Doolan, BJ; Varigos, GA1
Craiglow, BG; King, BA1
Mirmirani, P1
Dhayalan, A; King, BA1
Abramovits, W; Carviel, JL; Gupta, AK1
Gerdes, S; Gläser, R; Mrowietz, U; Schröder, O1
Craiglow, BG; King, BA; Liu, LY1
Craiglow, BG; Dai, F; King, BA; Liu, LY1
Ferreira, SB; Scheinberg, M1
Ferreira, R; Ferreira, SB; Jaller, AM; Jaller, JA; Jaller, JJ; Jaller-Char, JJ; Scheinberg, M1
Chang, SE; Choi, JH; Kang, YK; Koh, JK; Lee, JL; Lee, MW; Lee, WJ; Moon, KC1
Segal, AS1

Reviews

1 review(s) available for pyrroles and Alopecia Cicatrisata

ArticleYear
What's New in Hair Loss.
    Dermatologic clinics, 2019, Volume: 37, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Alopecia Areata; Azetidines; Humans; Janus Kinase Inhibitors; Nitriles; Piperidines; Platelet-Rich Plasma; Purines; Pyrazoles; Pyrimidines; Pyrroles; Retinoids; Sulfonamides

2019

Trials

2 trial(s) available for pyrroles and Alopecia Cicatrisata

ArticleYear
Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.
    International journal of dermatology, 2018, Volume: 57, Issue:12

    Topics: Administration, Cutaneous; Alopecia; Clobetasol; Double-Blind Method; Glucocorticoids; Hair; Humans; Janus Kinase Inhibitors; Nitriles; Ointments; Pilot Projects; Piperidines; Prospective Studies; Pyrazoles; Pyrimidines; Pyrroles

2018
Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Hair; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Time Factors; Young Adult

2019

Other Studies

39 other study(ies) available for pyrroles and Alopecia Cicatrisata

ArticleYear
Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.
    International journal of dermatology, 2022, Volume: 61, Issue:7

    Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Saudi Arabia; Treatment Outcome

2022
Oral tofacitinib for the treatment of alopecia areata in pediatric patients.
    Pediatric dermatology, 2022, Volume: 39, Issue:1

    Topics: Adolescent; Alopecia; Alopecia Areata; Child; Female; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome

2022
Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review.
    Dermatologic therapy, 2022, Volume: 35, Issue:4

    Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies

2022
Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib.
    Modern rheumatology case reports, 2022, 06-24, Volume: 6, Issue:2

    Topics: Adult; Alopecia; Alopecia Areata; Dermatomyositis; Female; Humans; Interferons; Piperidines; Pyrimidines; Pyrroles

2022
Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection.
    Journal of the American Academy of Dermatology, 2023, Volume: 88, Issue:5

    Topics: Alopecia; Alopecia Areata; COVID-19; Humans; Piperidines; Pyrroles

2023
Tofacitinib for Treatment of Alopecia Areata: Real-world Evidence and Factors Associated with Therapeutic Response.
    Acta dermato-venereologica, 2022, 06-15, Volume: 102

    Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles

2022
Oral tofacitinib for successful treatment of refractory alopecia areata in preschool children.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:12

    Topics: Alopecia; Alopecia Areata; Child, Preschool; Humans; Piperidines; Pyrimidines; Pyrroles

2022
Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population.
    Dermatologic therapy, 2022, Volume: 35, Issue:12

    Topics: Adult; Alopecia; Alopecia Areata; Arabs; Child; Cohort Studies; Female; Humans; Male; Prospective Studies; Pyrroles

2022
Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata.
    Dermatologic therapy, 2019, Volume: 32, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome; Young Adult

2019
Folliculitis decalvans responsive to tofacitinib: A case series.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Alopecia; Folliculitis; Humans; Piperidines; Pyrimidines; Pyrroles

2020
[Successful treatment of alopecia totalis with tofacitinib in a Danish patient].
    Ugeskrift for laeger, 2020, 08-24, Volume: 182, Issue:35

    Topics: Adult; Alopecia; Denmark; Humans; Male; Piperidines; Pyrimidines; Pyrroles

2020
[Alopecia areata with good response to tofacitinib].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2021, Volume: 72, Issue:6

    Topics: Alopecia; Alopecia Areata; Female; Humans; Middle Aged; Piperidines; Pyrimidines; Pyrroles

2021
Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alopecia universalis.
    Journal of cosmetic dermatology, 2021, Volume: 20, Issue:6

    Topics: Alopecia; Alopecia Areata; Humans; Minoxidil; Piperidines; Pyrimidines; Pyrroles

2021
Pediatric Game Changers∗: Oral tofacitinib for the treatment of alopecia areata in children.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:6

    Topics: Alopecia; Alopecia Areata; Child; Humans; Piperidines; Pyrimidines; Pyrroles

2021
Alopecia areata flare patterns in children and young adults while on systemic tofacitinib.
    Journal of the American Academy of Dermatology, 2022, Volume: 86, Issue:3

    Topics: Alopecia; Alopecia Areata; Child; Humans; Piperidines; Pyrimidines; Pyrroles; Young Adult

2022
Topical tofacitinib for the treatment of alopecia areata affecting facial hair.
    The British journal of dermatology, 2021, Volume: 185, Issue:3

    Topics: Administration, Topical; Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles

2021
Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis.
    Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4

    Topics: Administration, Oral; Adolescent; Alopecia; Child; Dermatologic Agents; Humans; Janus Kinase 1; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult

2017
Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment.
    Singapore medical journal, 2017, Volume: 58, Issue:5

    Topics: Adult; Alopecia; Female; Humans; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome

2017
Image Gallery: Treatment of refractory alopecia universalis with oral tofacitinib citrate and adjunct intralesional triamcinolone injections.
    The British journal of dermatology, 2017, Volume: 176, Issue:6

    Topics: Administration, Oral; Alopecia; Drug Therapy, Combination; Glucocorticoids; Humans; Injections, Intralesional; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Triamcinolone; Young Adult

2017
Excellent response to tofacitinib treatment in a patient with alopecia universalis.
    Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2017, Volume: 26, Issue:2

    Topics: Alopecia; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Young Adult

2017
Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
    Archives of dermatological research, 2017, Volume: 309, Issue:9

    Topics: Administration, Topical; Alopecia; Animals; Hair; Janus Kinase 3; Male; Mice; Mice, Inbred C57BL; Minoxidil; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Vascular Endothelial Growth Factor A

2017
Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.
    World journal of surgical oncology, 2018, Feb-06, Volume: 16, Issue:1

    Topics: Adult; Alopecia; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Indoles; Kidney Neoplasms; Krukenberg Tumor; Peritoneal Neoplasms; Pyrroles; Sunitinib; Treatment Outcome; Young Adult

2018
Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:6

    Topics: Administration, Topical; Adolescent; Alopecia; Alopecia Areata; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hair; Humans; Male; Pediatrics; Piperidines; Pyrimidines; Pyrroles; Sampling Studies; Treatment Outcome

2018
Tofacitinib for the treatment of lichen planopilaris: A case series.
    Dermatologic therapy, 2018, Volume: 31, Issue:6

    Topics: Administration, Oral; Adult; Aged; Alopecia; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Lichen Planus; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Retrospective Studies; Scalp; Scalp Dermatoses; Skin; Time Factors; Treatment Outcome

2018
Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.
    Acta dermato-venereologica, 2019, 01-01, Volume: 99, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Alopecia; Cyclopropanes; Cyclosporine; Female; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult

2019
Tofacitinib therapy for children with severe alopecia areata.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Alopecia; Alopecia Areata; Child, Preschool; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index

2019
Alopecia universalis. Partial response to tofacitinib.
    Medicina clinica, 2019, 08-02, Volume: 153, Issue:3

    Topics: Adult; Alopecia; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles

2019
An urticarial drug eruption caused by tofacitinib for alopecia universalis.
    Dermatologic therapy, 2019, Volume: 32, Issue:4

    Topics: Alopecia; Drug Eruptions; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Urticaria; Young Adult

2019
Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.
    The Journal of investigative dermatology, 2014, Volume: 134, Issue:12

    Topics: Adult; Alopecia; Dose-Response Relationship, Drug; Humans; Male; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Treatment Outcome

2014
Two birds that exclude each other: the Renbök phenomenon.
    The Journal of investigative dermatology, 2015, Volume: 135, Issue:4

    Topics: Alopecia; Humans; Male; Piperidines; Psoriasis; Pyrimidines; Pyrroles

2015
Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis.
    JAMA dermatology, 2016, Volume: 152, Issue:4

    Topics: Adult; Alopecia; Female; Humans; Janus Kinases; Male; Nail Diseases; Nails; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles

2016
Efficacy of tofacitinib in treatment of alopecia universalis in two patients.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:8

    Topics: Adult; Alopecia; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome

2016
Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
    Acta dermato-venereologica, 2017, 02-08, Volume: 97, Issue:2

    Topics: Adolescent; Alopecia; Alopecia Areata; Arthritis, Psoriatic; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retreatment

2017
Tofacitinib for the treatment of alopecia areata and variants in adolescents.
    Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1

    Topics: Adolescent; Alopecia; Alopecia Areata; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2017
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
    Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Aged; Alopecia; Alopecia Areata; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult

2017
Reversal of Alopecia Universalis by Tofacitinib: A Case Report.
    Annals of internal medicine, 2016, Nov-15, Volume: 165, Issue:10

    Topics: Adult; Alopecia; Female; Humans; Janus Kinase 1; Janus Kinase 3; Janus Kinase Inhibitors; Male; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult

2016
Recovery of nail dystrophy potential new therapeutic indication of tofacitinib.
    Clinical rheumatology, 2017, Volume: 36, Issue:4

    Topics: Adult; Alopecia; Female; Humans; Male; Nail Diseases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome

2017
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    The British journal of dermatology, 2009, Volume: 161, Issue:5

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Drug Eruptions; Female; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Skin Diseases; Sorafenib; Stomatitis; Sunitinib; Young Adult

2009
Alopecia associated with atorvastatin.
    The American journal of medicine, 2002, Aug-01, Volume: 113, Issue:2

    Topics: Adult; Alopecia; Atorvastatin; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrroles; Risk Assessment

2002